HOME CAREERS CONTACT US KOREAN ENGLISH

GENERAL MEETING OF STOCKHOLDERS

  1. HOME
  2. INVESTORS
  3. GENERAL MEETING OF STOCKHOLDERS

10th General Meeting of Stockholders of NeoImmuneTech

1. Date :10:00 A.M. March 29, 2024
2. Place : B1, Main conference room, Pangyo Innovalley C, 253 Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, Republic of Korea
3. Reporting Category
(1) Business report
(2) Auditor’s report
(3) Report on the operation status of the Internal Accounting Control System

4. Agenda
  • Agenda 1 : Approval of the Financial Statements for the Financial Year 2023
  • Agenda 2 : Change of basic articles of incorporation and subsidiary articles of incorporation
  • Agenda 3 : Appointment of Directors
  • Agenda 3-1 : Appointment of Executive Director (Luke Yun Suk Oh)
  • Agenda 3-2 : Appointment of Non-Executive Director (Sung June Hong)
  • Agenda 3-3 : Appointment of Outside Director(Choong Goo Kang)
  • Agenda 4 : Reappointment of Auditor(Sun Min Kim)
  • Agenda 5 : Approval of Limit on Remuneration of Directors (USD 5,000,000)
  • Agenda 6 : Approval of Limit on Remuneration of Statutory Auditor (USD 100,000)
  • Agenda 7 : Approval of granting of Stock Options
  • Agenda 8 : Grant of Stock Options
reference material

9th General Meeting of Stockholders of NeoImmuneTech

1. Date :10:00 A.M. March 31, 2023
2. Place : B1, Main conference room, Pangyo Innovalley C, 253 Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, Republic of Korea
3. Reporting Category
(1) Business report
(2) Report on the operation status of the Internal Accounting Control System
(3) Auditor’s report
(4) External auditor appointment report

4. Agenda
  • Agenda 1 : Approval of the Financial Statements for the Financial Year 2022
  • Agenda 2 : Reappointment of Directors
  • Agenda 2-1 : Reappointment of Non-Executive Director (Jung Won Woo)
  • Agenda 2-2 : Reappointment of Independent Director (Jin-Hyoung Kang)
  • Agenda 3 : Approval of Limit on Remuneration of Directors (USD 5,000,000)
  • Agenda 4 : Approval of Limit on Remuneration of Statutory Auditor (USD 100,000)
  • Agenda 5 : Approval of granting of stock options (The board of directors)
  • Agenda 6 : Grant of Stock Options
reference material

8th General Meeting of Stockholders of NeoImmuneTech

1. Date : 10:00 AM. Mar 31, 2022
2. Place : B1, Main conference room, Pangyo Innovalley C, 253 Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, Republic of Korea
3. Reporting Category
(1) Auditor’s Report
(2) Business Report

4. Agenda
  • Agenda 1 : Approval of the Financial Statements for the Financial Year 2021
  • Agenda 2 : Reappointment of Directors
  • Agenda 2-1 : Reappointment of Standing Director
  • Agenda 2-2 : Reappointment of Outside Director
  • Agenda 3 : Approval of Limit on Remuneration of Directors (USD 5,000,000)
  • Agenda 4 : Approval of Limit on Remuneration of Statutory Auditor (USD 100,000)
  • Agenda 5 : Approval of the grant of stock options pursuant to the Board of Directors’ resolution on September 28, 2021
  • Agenda 6 : Grant of Stock Options
reference material
Results of the 8th general meeting of shareholders

(Share present : 9,914,326 / 19,716,402 (50.28%))

Agenda Result
Agenda 1 Approval of the Financial Statements for the Financial Year 2021 Approved
Agenda 2

Agenda 2-1
Agenda 2-2 		Reappointment of Directors

Reappointment of Standing Director
Reappointment of Outside Director

Approved
Approved
Agenda 3 Approval of Limit on Remuneration of Directors (USD 5,000,000) Approved
Agenda 4 Approval of Limit on Remuneration of Statutory Auditor (USD 100,000) Approved
Agenda 5 Approval of the grant of stock options pursuant to the Board of Directors’ resolution on September 28, 2021 Approved
Agenda 6 Grant of Stock Options Approved

※ Shares present : Total number of the common shares with voting rights represented at the opening of the Meeting basis

7th General Meeting of Stockholders of NeoImmuneTech

1. Date : 10:00 AM. Mar 31, 2021 (KST)
2. Place : 6F, 26, Yeongdong-daero 96-gil, Gangnam-gu, Seoul, Republic of Korea
3. Agenda
  • Agenda 1 : Approval of the Financial Statements for the Financial Year 2020
  • Agenda 2 : Appointment of Directors
  • Agenda 2-1 : Reappointment of Independent Director: Byoung Jo Kang
  • Agenda 2-2 : Appointment of Independent Director: Jin-Hyoung Kang
  • Agenda 2-3 : Appointment of Non-Executive Director: Jung Won Woo
  • Agenda 3 : Reappointment of Statutory Auditor (Sun min Kim)
  • Agenda 4 : Approval of Limit on Remuneration of Directors (USD 5,000,000)
  • Agenda 5 : Approval of Limit on Remuneration of Statutory Auditor (USD 100,000)
  • Agenda 6 : Grant of Stock Options (Jin-Hyoung Kang, Byoung Jo Kang, Gene Namgoong)
  • Agenda 7 : Approval of the grant of stock options pursuant to the Board of Directors’ resolution
Results of the 7th general meeting of shareholders

(Share present : 9,429,204 / 16,545,068 (56.99%))

Agenda Results
Agenda 1 Approval of the Financial Statements for the Financial Year 2021 Approved
Agenda 2

Agenda 2-1
Agenda 2-2
Agenda 2-3 		Reappointment of Directors

Reappointment of Independent Director: Byoung Jo Kang
Appointment of Independent Director: Jin-Hyoung Kang
Appointment of Non-Executive Director: Jung Won Woo

Approved
Approved
Approved
Agenda 3 Reappointment of Statutory Auditor (Sun min Kim) Approved
Agenda 4 Approval of Limit on Remuneration of Directors (USD 5,000,000) Approved
Agenda 5 Approval of Limit on Remuneration of Statutory Auditor (USD 100,000) Approved
Agenda 6 Grant of Stock Options (Jin-Hyoung Kang, Byoung Jo Kang, Gene Namgoong) Approved
Agenda 7 Approval of the grant of stock options pursuant to the Board of Directors’ resolution Approved

※ Shares present : Total number of the common shares with voting rights represented at the opening of the Meeting basis